With Walmart's continued operational improvements and a recovering economy, patient investors should expect shares to approach the lower $85 by the second half of the year.
Playing earnings correctly can sometimes be the difference between a passing and a failing portfolio.
Apple needs to be on the offensive having allowed competitors like Google and Samsung to challenge its once-dominant market.
Monsanto projects to approach $130 in the next 12 to 18 months.
There is just too much on the line for disappointment if Apple can't provide the revolutionary product the world has been waiting for.
With its stock trading at just 11 times 2015 estimates, which is 2 points below the industry average, Wells Fargo remains the best bargain in banking.
JPMorgan's reputation can only improve from this point forward. Any negativity is already priced into the stock.
We're only four months into the year, but I don't believe I will read a worse article on Apple than the one written by Forbes contributor Peter Cohan.
Not many investors placed winning bets against Steve Jobs. Do you want to make the mistake of betting against Tesla's Elon Musk?
Despite declining revenue and earnings, Alcoa is in no worse shape than it was a year ago.